9 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 9 of 9 clinical reviews.
Everything you need to know about Dayvigo (lemborexant) and anesthesia interactions, including when to hold the dose, what to tell your anesthesiologist, and how alcohol fits into this picture.
A guide to the lemborexant, estradiol HRT drug interaction: CYP3A4 metabolism, pharmacodynamic overlap, VTE and CNS risk, dose guidance, and monitoring protocols.
Is it safe to take Dayvigo (lemborexant) with finasteride? A guide covering CYP metabolism, pharmacodynamic overlap, monitoring recommendations, and dose-adjustment guidance.
Can you take Dayvigo (lemborexant) with gabapentin? Learn about the pharmacodynamic interaction, CNS depression risk, dose adjustments, and monitoring recommendations backed by clinical evidence.
Board-reviewed analysis of the lemborexant (Dayvigo) and metformin drug interaction, covering CYP metabolism, pharmacodynamic overlap, monitoring, and dose adjustment guidance.
A clinical deep-dive into the lemborexant (Dayvigo) and progesterone HRT drug interaction, covering CYP3A4 pharmacokinetics, additive sedation risk, dose-adjustment guidance, and patient counseling points.
A guide to the lemborexant, sildenafil drug interaction: CYP3A4 mechanism, hypotension risk, dose guidance, and monitoring for patients taking both Dayvigo and sildenafil.
A clinical review of the lemborexant, tadalafil drug interaction, covering CYP3A4 metabolism, pharmacodynamic overlap, severity grading, dose adjustments, and patient counseling.
A clinical review of the lemborexant (Dayvigo) and testosterone interaction, covering CYP3A4 metabolism overlap, sleep apnea risk, monitoring considerations, and what remains unverified.